Living with primary immunodeficiency (PI) isn’t always easy, but it’s important to remember that you are not alone.
MyIgSource is a comprehensive program that can support you throughout your PI journey. Connect with Patient Advocates for emotional support, ask Nurse Advocates your treatment-related questions, get help understanding insurance, learn about prescription savings, and access educational resources. What's more, MyIgSource is open to all patients and caregivers regardless of treatment.
Our MyIgSource program is all about supporting you on your journey with PI. Whether you are a patient or a caregiver, just diagnosed or have been living with PI for a long time, we're here for you. Find out more on our About MyIgSource page.
Our Nurse Advocates can answer questions about administration and help you talk to your doctor about treatment, while our Patient Advocates are real PI patients and caregivers who understand what you are going through and are here to talk. To learn more, visit our Meet the Advocates page.
We offer a host of complimentary resources and tools for you to better understand and manage PI, all designed with you in mind. To see all we have to offer, visit our Support Resources page.
GAMMAGARD LIQUID is used to treat patients two years of age and older with primary immunodeficiency diseases (PI). There are many forms of PI. GAMMAGARD LIQUID contains antibodies collected from healthy people that replace the missing antibodies in PI patients.
GAMMAGARD LIQUID is also used to treat adult patients with Multifocal Motor Neuropathy (MMN), a rare disease that causes muscle weakness that worsens over time.
Detailed Important Risk Information
Stop the infusion immediately and contact your healthcare provider or call emergency services if you have any of the following:
Symptoms of thrombosis (blood clots) that may include: pain and/or swelling of an arm or leg with warmth over the affected area, discoloration (redness) or lump in an arm or leg, unexplained shortness of breath, chest pain or discomfort that worsens on deep breathing, unexplained rapid pulse, numbness or weakness on one side of the body.
Symptoms of a kidney problem that may include: reduced urination, sudden weight gain or swelling in your legs.
Symptoms of a serious allergic reaction that may include: hives, skin rash, itching, swelling in the mouth or throat, trouble breathing, wheezing, fainting or dizziness.
Other serious symptoms including: bad headache with nausea, vomiting, stiff neck, drowsiness, fever, sensitivity to light, painful eye movements; blurred vision; brown or red urine, fast heart rate, yellow skin or eyes; trouble breathing, blue lips or extremities; fever over 100°F.
Tell your healthcare provider if you have a history of thrombosis (blood clots), thrombotic events, poor kidney function or kidney failure.
Do not use GAMMAGARD LIQUID if you have a known history of a severe allergic reaction to immune globulin or other blood products. If you have such a history, discuss this with your healthcare provider to determine if GAMMAGARD LIQUID can be given to you. Tell your healthcare provider if you have a condition called selective (or severe) immunoglobulin A deficiency.
GAMMAGARD LIQUID is made from human blood. It may contain infectious agents that can cause disease e.g., viruses, the variant Creutzfeldt-Jakob disease (vCJD), and theoretically, the Creutzfeldt-Jakob disease agent. Patients should report any symptoms that concern them which might be caused by virus infections.
GAMMAGARD LIQUID can make vaccines (e.g., measles, mumps, rubella, or chicken pox vaccines) not work as well. It may also affect your blood test results. Before you get any vaccines or have your blood tested, tell your healthcare provider that you take GAMMAGARD LIQUID.
The following is a list of common side effects seen in clinical trials of GAMMAGARD LIQUID:
PI (Subcutaneous administration): Infusion site reactions (i.e., mild or moderate pain, swelling, itching, redness, bruising, and/or warmth), headache, fatigue, increased heart rate, fever, upper abdominal pain, nausea, vomiting, asthma, increased blood pressure, diarrhea, ear pain, canker sores, migraine, sore throat, and pain in extremity.
MMN (IV administration): Headache, chest discomfort, muscle spasms, muscular weakness, nausea, sore throat, ear pain, and pain in extremity.
Although it is possible to receive IV infusions at home, they are more often given in a hospital or infusion center by a nurse. Whenever giving yourself treatments at home, you should have another responsible person present to help treat side effects or get help should a serious adverse reaction occur. Ask your healthcare provider whether you should have rescue medications, such as antihistamines or epinephrine.
Baxalta, Gammagard, Gammagard Liquid, Hyqvia, Igi, and the Myigsource logo are trademarks of Baxalta Incorporated.
All other product brands or trademarks appearing herein are the property of their respective owners.
You are now leaving GAMMAGARD.com
The browser window or tab for GAMMAGARD.com will remain open underneath the new browser window or tab. To return to GAMMAGARD.com at any time, close this tab or window.
This manufacturer's coupon program is not valid for prescriptions reimbursed, in whole or in part, by Medicaid, Medicare, Medigap, VA, DoD, TRICARE, or any other federal or state healthcare programs, including state pharmaceutical assistance programs, and where prohibited by the health insurance provider or by law.
MyIgCoPayCard program provides a maximum total benefit of $5,000 for eligible out-of-pocket costs and expires 12 months from date of activation. Eligible costs include deductible, copayment, and co-insurance costs for eligible Baxalta IG products. Non-medication expenses, such as ancillary supplies or administration-related costs, are not eligible.
To be eligible, patients must: 1. be starting or receiving treatment with (and have current prescription for) an eligible Baxalta IG product with an ICD-10 code for a diagnosis of Primary Immunodeficiency; and 2. have commercial insurance that covers medication costs for prescribed Baxalta IG product and allows for CoPay assistance; and 3. be two (2) years old or older.
Acceptance of this offer must be consistent with the terms of benefits provided by patient’s health insurance provider.
Offer limited to one card per person and may not be combined with any other coupon, discount, prescription savings card, rebate, free trial, patient assistance, or other offer.
This program is only valid for residents of the United States, excluding Puerto Rico and other U.S. territories.
Baxalta reserves the right to change or discontinue this program at any time without notice.
This is not health insurance.
By using this coupon, you are certifying that:
1) You meet the eligibility criteria and have read and agree to the terms and conditions of this manufacturer coupon program;
2) You will not, at any time, submit any costs for the product dispensed pursuant to this coupon to any government healthcare program for reimbursement;
3) You are permitting your personal information, including name, address, phone number, email address, and information related to health insurance and treatment, to be shared with Baxalta and companies working with Baxalta for the purpose of administering this program; and
4) You will notify your health insurance provider or other third-party payer of the use of this coupon if required to do so.
If your insurance situation changes it is your responsibility to notify Baxalta's MyIgCoPayCard program.
For questions about this program, patients and caregivers can call MyIgSource at (855) 250-5111.
By submitting a claim for reimbursement pursuant to this manufacturer coupon program, the Pharmacy represents and warrants that:
1) It has dispensed GAMMAGARD LIQUID treatment to an eligible patient and in accordance with the terms and conditions of this program and the accompanying prescription;
2) Its participation in this program is consistent with all applicable laws and any obligations, including its contract with the applicable payer;
3) If the patient's insurance situation changes, it will notify Baxalta immediately by contacting the MyIgCoPayCard program;
4) It will report coupon assistance received to payers if so required; and
5) The entire benefit amount received will go to eligible expenses and it will not retain any portion of the benefit as payment to it for administration or ineligible expenses.
For questions regarding processing, claim transmission, patient eligibility, or other issues, pharmacists can call the MyIgCoPayCard program directly at (855) 217-1615.